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Chronic kidney disease (CKD) is kidney damage that occurs for more than 3 
months with a glomerular filtration rate of less than 60 ml/sec/ 1.73 m2. WHO 
estimates that in Indonesia, there will be an increase in PGK in 1995-2025 by 
41.4%. Over the past 40 years, Creatinine serum has become the most 
common and cheap serum marker for kidney function. One of the most 
common complications in patients with PGK is anemia. Anemia in PGK can be 
caused by several factors such as EPO deficiency, iron deficiency, etc. One of 
the usual parameters checking is the iron status of TIBC. This study aims to 
determine the relationship of serum Creatinine level with TIBC in chronic 
kidney patients in Gambiran regional public hospital Kediri and sampling taken 
by quota sampling. The study used cross-sectional using Rank Spearman 
statistic test. This test is used for abnormally distributed data types. The 
measured variable was serum Creatinine level with TIBC. The results of this 
study indicate that the value of p = (0.000)> α = (0.05), so H1 rejected and H0 
accepted, then there is no relationship between serum Creatinine levels with 
TIBC in patients with chronic kidney disease in Gambiran Hospital Kediri. 
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INTRODUCTION 
Chronic kidney disease (CKD) is a pathophysiological process with a variety of 
etiologies, resulting in a progressive decrease in kidney function, and generally ends with 
kidney failure. Chronic kidney disease has become a major health problem in the world 
community.1 
Chronic kidney disease (CKD) is one of the common causes of renal failure. It 
involves a progressive loss over the course of months in the structure and function of the 
kidneys, with or without a decreased glomerular filtration rate (GFR). CKD can be 
diagnosed by its pathological abnormalities, changes in the levels of kidney function 
markers in the blood or urine, or by imaging investigations.2 
Chronic kidney disease is a significant cause of morbidity and mortality world wide. 
In India, there is a rising incidence and prevalence of kidney failure, with poor outcomes 
and high cost. The hallmark of CKD is 
structural and functional damage of the glomeruli of the kidney.The most important 
outcomes of this kidney damage are loss of kidney function and cardiovascular disease 
leading to premature death.3 
 The prevalence of chronic kidney failure in America is around 5% -37% between 
1980-2001.4 The prevalence of chronic kidney failure in Indonesia is around 0.2%.5 The 
prevalence of the ≥ 75 year age group is 0.6% higher than other age groups.6 Based on 
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data from RSUD Gambiran Kediri, the results of preliminary observations of chronic 
kidney disease patients were approximately 135 per month in 2017. 
Chronic kidney disease is kidney damage with a glomerular filtration rate / LFG of 
less than 60 ml / min / 1.73m2 characterized by a structural abnormality or impaired renal 
function irreversible and has lasted for three months or more, with or without a gradual 
and sustained reduction in glomerular filtration rates.7 
Rate Glomerular filtration (LFG) is a plasma volume that can be completely cleaned 
of certain compounds by the kidneys in one unit of time. Serum creatinine is the most 
well-known endogenous marker used to estimate LFG. Although its use has been 
recognized since the beginning of the 20th century, serum creatinine has limitations both 
physiologically and analytically. Physiologically, the two main limitations of using serum 
creatinine to estimate LFG are variations in creatinine tubular secretion and the 
dependence of serum creatinine excretion on muscle mass.8 
According to Astrid's research, with the title "Overview of Serum Creatinine Levels in 
Kidney Disease patients in Stage 5 non-dialysis Chronic" using a cross-sectional 
descriptive design, a sample of 35 people was used. Test results obtained for all patients 
diagnosed with non-dialysis stage 5 chronic kidney disease have increased serum 
creatinine levels (100%) due to renal dysfunction. Creatinine filtration ability will decrease 
and serum creatinine will increase.1 
Chronic kidney disease is usually associated with anemia and the level of anemia 
correlates with the severity of the renal failure. The anemia of renal failure has been 
attributed to a relative deficiency of erythropoietin, but absolute deficiencies of iron or 
folate may also play a role.  Other contributing factors include heavy-  metal toxicity, blood 
loss, and a reduction in red cell survival induced by toxic radicals.  The treatment  of  the 
anemia  of  renal  disease  has advanced with the development of recombinant human 
erythropoietin.9 
Anemia is one of the complications that occur in CKD patients with an incidence rate 
of 80-90%. If severe kidney damage occurs, the production of erythropoietin in the 
kidneys is disrupted so that red blood cell production is reduced. Along with kidney 
damage, bleeding, iron deficiency accompanied by a decrease in glomerular filtration rate, 
the degree of anemia will increase.10 
Anemia of renal failure begins relatively early in the development of kidney disease. 
As the destruction of the kidney progresses, the degree of anemia increases. Although 
there is a large degree of the patient to patient variability, the Hct generally begins to fall 
when the plasma creatinine concentration is above 2 mg/dl and gets lower asglomerular 
filtration rate (GFR) declines.11 
Anemia prevalence worldwide was estimated at 33% in 2010 with iron deficiency 
being the leading cause in half of the cases. In chronic kidney disease (CKD) patients, 
anemia is a clinically significant burden and it becomes more prevalent with declining 
glomerular filtration rate (GFR). Anemia is associated with reduced quality of life and 
increased cardiovascular morbidity and mortality. Erythropoietin (EPO) deficiency remains 
the major cause of anemia in CKD patients due to the decrease in renal EPO 
production.12 
Anemia in CKD can also be caused by iron deficiency. Iron deficiency anemia can 
be diagnosed using conventional iron status laboratory examinations such as serum iron 
(SI), Total Iron Binding Capacity (TIBC), transferrin saturation, and serum ferritin.13 
Iron is essential for oxygen binding in red blood cells and is crucial for many other 
cellular functions. Iron deficiency, even without anemia, has been demonstrated to be an 
independent risk factor for increased mortality.2 Iron deficiency anaemiais also common in 
patients with chronic kidney disease. Iron deficiency may be absolute, often due to poor 
dietary intake or sometimes occult bleeding, or functional, when there is an imbalance 
between the iron requirements of the erythroid marrow and the actual iron supply.14 
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According to previous research, uses descriptive research design, the sample used 
92 people and processed using Pearson correlation statistical test and Kolmogorov-
Smirnov categorical test. Evaluating TIBC values, where 80% of CKD patients experience 
decreased TIBC levels.15 
The high prevalence of anemia in patients with Chronic Kidney Disease (GGK) and 
the number of iron status parameters that can be used to see changes in iron metabolism 
in these patients requires a specific and sensitive parameter to determine iron status, 
namely Fe and TIBC parameters (Total Iron Binding Capacity). Both parameters are 
better than if only checking hemoglobin levels, which are less sensitive to determine iron 
status, especially in mild anemia in patients with chronic renal failure.13 
 
 
MATERIALS AND METHODS 
This research was conducted at the Laboratory of Gambiran Hospital in Kediri City 
in July-August 2017. The population of this study was all patients with Chronic Kidney 
Disease at Gambiran Hospital, Kediri City. The sample used in this study was 32 patients 
with CKD in Gambiran Hospital, Kediri City. The sampling technique in this study was to 
use a Non-Random (Non Probability) Quota Sampling. Quota sampling is quotum 
sampling or quota, done by determining how many samples are needed. Any population 
member to be taken is not a problem, the important number of quotums that have been 
determined can be fulfilled.16 With a sample size of 32 chronic kidney disease in 
Gambiran Hospital, Kediri City. The number of samples where the appropriate sample 
size in the study is between 30 and 500.17 
In this study using data analysis using a correlation study test. Correlation test is a 
statistical tool that can be used to compare the measurement results of 2 different 
variables in order to determine the level of relations between variables. Correlation test 
used is Pearson test for a parametric test (normal data distribution) which is used to find 
the relationship of two or more variables, but if the distribution of data is not normal it can 
be used non-parametric statistical test namely spearman test SPSS 16.0 program.18 
 
RESULTS AND DISCUSSION 
Table 1: Data on Creatinine and TIBC results in patients with chronic kidney 
disease in Gambiran Hospital Kediri city 
 
Sample 
Code 
 
 
age 
Results 
Creatinine TIBC 
(mg/dl) (µl/dl) 
A1 60 5,1 200,2 
A2 57 11,95 251,5 
A3 47 7,8 217,9 
A4 47 5,6 318 
A5 55 13,4 213,6 
A6 73 16,3 233,5 
A7 71 10,1 262,6 
A8 69 12,3 233,9 
A9 53 9,19 258 
A10 67 10,84 268 
A11 60 6,5 321 
A12 75 25,3 238,3 
A13 56 7,4 304 
A14 71 13 226 
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A15 66 10,9 159,9 
A16 60 10,1 227,4 
A17 73 13 207 
A18 63 8,9 298,8 
A19 58 3,3 214,3 
A20 45 8,8 213,7 
A21 33 2 142 
A22 57 8,1 277,4 
A23 68 10,8 162,5 
A24 56 4,2 216,9 
A25 66 13,3 195,6 
A26 69 28,3 181,3 
A27 42 6,8 194 
A28 73 12,8 244,3 
A29 62 5,1 250,9 
A30 70 11 287,4 
A31 52 9,2 162 
A32 68 18 222,8 
 
In chronic renal failure, there is a steady and continued decrease in renal 
clearance or glomerular filtration rate (GFR), which leads to the gathering of urea, 
creatinine and other chemicals in the blood. GFR  of less than 60  mL/minute/1.73  m2 is 
the indication of CKD.19 KDIGO additional classified the  CKD in different stages which 
are: GFR 30 to 60 mL/minute as stage three; GFR 15 to 30 mL/minute as stage four; and 
GFR less than 15 mL/minute as stage five of CKD.  In  stage  five  level  of  serum 
creatinine is  greater than 5.0 mg/dl  in men, and  greater than 4.0 mg/dl in women.20 
it can be seen that 32 CKD patients experienced an increase in serum creatinine 
(100%). This result is not much different from the research conducted at the RSUD dr. 
Moewardi Surakarta, which shows that there were 31 patients (93.9%) who had high 
creatinine levels. Over the past 40 years, serum creatinine has become the most common 
and inexpensive serum marker to determine kidney function. Serum creatinine 
examination is also very helpful in carrying out therapy in patients with kidney function 
disorders. High and low creatinine levels in the blood are used as important indicators in 
determining whether a person with impaired renal function needs hemodialysis or not. If 
renal dysfunction occurs, creatinine filtration ability will decrease and serum creatinine will 
increase. A doubling of serum creatinine levels indicates a decrease in kidney function by 
50%, as well as a threefold increase in serum creatinine reflecting a decline in kidney 
function by 75%. One of the most important kidney functions is the excretion of metabolic 
waste products such as creatinine. The function is very disturbed in patients with non-
dialysis kidney failure as a result of increased serum creatinine levels. Therefore, serum 
creatinine levels are used as an important indicator to determine kidney function.1 
The amount of creatinine released by a person every day depends more on 
muscle mass than muscle mass or protein metabolism, this causes creatinine values in 
men to be higher because the amount of male muscle mass is greater than the amount of 
muscle mass of women. Muscle mass and protein metabolism generally cause a constant 
effect of creatinine formation, except if there is a severe physical injury or degenerative 
disease that causes damage to muscles.21 
In this study, it was found that many samples had decreased TIBC values. This is 
consistent with previous research, that the sample with a TIBC value decreased more 
than the normal TIBC value.22 TIBC which decreases in CKD can be caused by increased 
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ferritin or can occur in anemia of chronic diseases that occur inflammation. However, in 
regular hemodialysis patients can experience iron deficiency anemia due to blood loss.15 
In CKD group, iron metabolism is altered compared to controls. Here, serum iron 
levels are low due to inadequate secretion of erythropoietin, erythropoiesis is halted 
leading to decreased Hb and serum iron. Serum ferritin stores are not utilized due to 
associatedinflammation giving rise to near normal ferritin levels.23 
From the results of the study entitled the relationship of serum creatinine with TIBC 
in patients with chronic kidney disease in Gambiran Hospital, Kediri City showed that 
there was no statistical relationship between serum creatinine and TIBC with p> 0.05. The 
results of this study support the theory in the study entitled "Iron chronic disease kidney 
disease patients" that there was no significant relationship between serum creatinine and 
TIBC in chronic kidney patients.6 This is probably because not all people with chronic 
kidney disease are caused by iron deficiency anemia. Iron deficiency anemia in patients 
with CKD is mainly caused by poor nutritional intake, impaired absorption, chronic 
bleeding, inflammation or infection, and increased iron requirements during correction of 
anemia with Erythropoietin Stimulating Agent (ESA) therapy.24 The other causes than iron 
deficiency, such as erythropoietin deficiency, uremia related inhibition of erythropoiesis, 
and short life span of the red blood cell may be responsible for anemia in those subjects.25 
 
CONCLUSIONS 
Based on the results of the study, the relationship between serum creatinine levels 
and TIBC in patients with chronic kidney disease in Gambiran Hospital, Kediri City can be 
concluded that Statistically, there is no correlation between serum creatinine and TIBC in 
patients with chronic kidney disease with p> 0.05. This is because anemia in CKD is 
mainly caused by reduced production of erythropoietin (EPO) and not all sufferers of 
chronic kidney disease have iron deficiency anemia. 
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